Compare SEB & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEB | XENE |
|---|---|---|
| Founded | 1918 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.2B |
| IPO Year | 1994 | 2014 |
| Metric | SEB | XENE |
|---|---|---|
| Price | $4,555.57 | $68.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $68.55 |
| AVG Volume (30 Days) | 5.1K | ★ 1.7M |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 467.71 | N/A |
| EPS | ★ 124.24 | N/A |
| Revenue | ★ $5,809,000,000.00 | $311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,496.48 |
| P/E Ratio | $37.17 | ★ N/A |
| Revenue Growth | ★ 7.99 | N/A |
| 52 Week Low | $2,990.00 | $30.00 |
| 52 Week High | $5,989.37 | $72.66 |
| Indicator | SEB | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 70.44 |
| Support Level | $4,265.35 | $52.40 |
| Resistance Level | $4,800.00 | $72.66 |
| Average True Range (ATR) | 158.52 | 2.68 |
| MACD | 24.19 | 0.39 |
| Stochastic Oscillator | 59.80 | 69.51 |
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.